concentrix corp - CNXC
CNXC
Close Chg Chg %
41.42 0.76 1.83%
Closed Market
42.18
+0.76 (1.83%)
Volume: 1.26M
Last Updated:
Jan 15, 2026, 4:00 PM EDT
Company Overview: concentrix corp - CNXC
CNXC Key Data
| Open $41.34 | Day Range 40.93 - 43.16 |
| 52 Week Range 31.63 - 66.00 | Market Cap $2.58B |
| Shares Outstanding 62.26M | Public Float 43.53M |
| Beta 0.48 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$20.82 |
| Yield 346.67% | Dividend $0.36 |
| EX-DIVIDEND DATE Jan 30, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.05M |
CNXC Performance
| 1 Week | -5.99% | ||
| 1 Month | 4.68% | ||
| 3 Months | -7.65% | ||
| 1 Year | -15.40% | ||
| 5 Years | -65.55% |
CNXC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
4
Full Ratings ➔
About concentrix corp - CNXC
Concentrix Corp. engages in the provision of customer experience solutions and technology. The company was founded in 1973 and is headquartered in Newark, CA.
CNXC At a Glance
Concentrix Corp.
39899 Balentine Drive
Newark, California 94560
| Phone | 1-800-747-0583 | Revenue | 9.83B | |
| Industry | Information Technology Services | Net Income | -1,278,924,000.00 | |
| Sector | Technology Services | 2025 Sales Growth | 2.151% | |
| Fiscal Year-end | 11 / 2026 | Employees | N/A | |
| View SEC Filings |
CNXC Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.232 |
| Price to Book Ratio | 0.815 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 5.234 |
| Enterprise Value to Sales | 0.671 |
| Total Debt to Enterprise Value | 0.704 |
CNXC Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | 4.915 |
| Total Asset Turnover | 0.864 |
CNXC Liquidity
| Current Ratio | 1.404 |
| Quick Ratio | N/A |
| Cash Ratio | 0.149 |
CNXC Profitability
| Gross Margin | 28.343 |
| Operating Margin | 6.204 |
| Pretax Margin | -12.032 |
| Net Margin | -13.016 |
| Return on Assets | -11.242 |
| Return on Equity | -37.704 |
| Return on Total Capital | -17.323 |
| Return on Invested Capital | -15.302 |
CNXC Capital Structure
| Total Debt to Total Equity | 169.021 |
| Total Debt to Total Capital | 62.828 |
| Total Debt to Total Assets | 43.105 |
| Long-Term Debt to Equity | 166.63 |
| Long-Term Debt to Total Capital | 61.939 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Concentrix Corp - CNXC
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 6.32B | 7.11B | 9.62B | 9.83B | |
Sales Growth
| +13.20% | +12.49% | +35.20% | +2.15% | |
Cost of Goods Sold (COGS) incl D&A
| 4.35B | 4.91B | 6.87B | 7.04B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 309.54M | 388.30M | 705.85M | 650.11M | |
Depreciation
| 146.86M | 173.46M | 246.92M | 215.78M | |
Amortization of Intangibles
| 162.67M | 214.83M | 458.93M | 434.33M | |
COGS Growth
| +11.05% | +12.94% | +39.92% | +2.46% | |
Gross Income
| 1.98B | 2.20B | 2.75B | 2.78B | |
Gross Income Growth
| +18.23% | +11.51% | +24.68% | +1.38% | |
Gross Profit Margin
| +31.24% | +30.97% | +28.56% | +28.34% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 1.27B | 1.45B | 1.99B | 2.18B | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 1.27B | 1.45B | 1.99B | 2.18B | |
SGA Growth
| +10.85% | +14.74% | +36.96% | +9.37% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 91.75M | 154.84M | 117.56M | 1.53B | |
EBIT after Unusual Expense
| 618.44M | 596.21M | 640.48M | (916.23M) | |
Non Operating Income/Expense
| 56.64M | (12.54M) | (19.38M) | 24.35M | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 70.08M | 175.45M | 321.83M | 290.35M | |
Interest Expense Growth
| +204.07% | +150.37% | +83.43% | -9.78% | |
Gross Interest Expense
| 70.08M | 175.45M | 321.83M | 290.35M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 605.00M | 408.23M | 299.27M | (1.18B) | |
Pretax Income Growth
| +8.87% | -32.52% | -26.69% | -495.03% | |
Pretax Margin
| +9.57% | +5.74% | +3.11% | -12.03% | |
Income Tax
| 169.36M | 94.39M | 48.06M | 96.70M | |
Income Tax - Current - Domestic
| - | 70.57M | 90.03M | 97.72M | |
Income Tax - Current - Foreign
| - | 129.61M | 126.07M | 185.58M | |
Income Tax - Deferred - Domestic
| - | (31.90M) | (110.22M) | (124.70M) | |
Income Tax - Deferred - Foreign
| - | 1.07M | (11.49M) | (110.55M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | (6.63M) | (6.00M) | (9.50M) | |
Consolidated Net Income
| 429.01M | 307.84M | 241.71M | (1.28B) | |
Minority Interest Expense
| - | - | - | 591.00K | - |
Net Income
| 428.42M | 307.84M | 241.71M | (1.28B) | |
Net Income Growth
| +7.16% | -28.14% | -21.48% | -629.11% | |
Net Margin Growth
| +6.77% | +4.33% | +2.51% | -13.02% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 428.42M | 307.84M | 241.71M | (1.28B) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 428.42M | 307.84M | 241.71M | (1.28B) | |
EPS (Basic)
| 8.3426 | 5.7218 | 3.72 | -20.2965 | |
EPS (Basic) Growth
| +7.16% | -31.41% | -34.99% | -645.60% | |
Basic Shares Outstanding
| 51.35M | 53.80M | 64.98M | 63.01M | |
EPS (Diluted)
| 8.2811 | 5.7001 | 3.7146 | -20.36 | |
EPS (Diluted) Growth
| +7.52% | -31.17% | -34.83% | -648.11% | |
Diluted Shares Outstanding
| 51.74M | 54.01M | 65.07M | 63.01M | |
EBITDA
| 1.02B | 1.14B | 1.46B | 1.26B | |
EBITDA Growth
| +26.42% | +11.73% | +28.49% | -13.95% | |
EBITDA Margin
| +16.12% | +16.01% | +15.22% | +12.82% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 65.00 | |
| Number of Ratings | 4 | Current Quarters Estimate | 2.645 | |
| FY Report Date | 02 / 2026 | Current Year's Estimate | 11.865 | |
| Last Quarter’s Earnings | 2.95 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 11.22 | Next Fiscal Year Estimate | 13.125 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 4 | 4 | 4 | 4 |
| Mean Estimate | 2.65 | 2.76 | 11.87 | 13.13 |
| High Estimates | 2.66 | 2.84 | 12.04 | 13.84 |
| Low Estimate | 2.63 | 2.68 | 11.74 | 12.51 |
| Coefficient of Variance | 0.49 | 2.48 | 1.14 | 4.32 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 3 | 3 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 1 | 2 | 2 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Concentrix Corp - CNXC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Concentrix Corp - CNXC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Dec 4, 2025 | Christopher A. Caldwell President and CEO; Director | 280,586 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $36.52 per share | 10,247,000.72 |
| Dec 3, 2025 | Cormac Twomey EVP, Global Ops & Delivery | 35,130 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $35.5 per share | 1,247,115.00 |
| Apr 18, 2025 | Olivier Fabrice Duha Director | 292,360 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50.08 per share | 14,641,388.80 |
| Apr 18, 2025 | Olivier Fabrice Duha Director | 280,721 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.19 per share | 13,527,944.99 |
| Apr 18, 2025 | Olivier Fabrice Duha Director | 292,588 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $49.46 per share | 14,471,402.48 |
| Apr 18, 2025 | Olivier Fabrice Duha Director | 299,042 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.24 per share | 14,425,786.08 |
| Apr 18, 2025 | Olivier Fabrice Duha Director | 9,499 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.21 per share | 457,946.79 |
| Apr 18, 2025 | Olivier Fabrice Duha Director | 16,675 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $49.42 per share | 824,078.50 |
| Apr 18, 2025 | Olivier Fabrice Duha Director | 23,568 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.3 per share | 1,138,334.40 |
| Apr 18, 2025 | Olivier Fabrice Duha Director | 1,144,350 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.2 per share | 55,157,670.00 |
| Apr 18, 2025 | Olivier Fabrice Duha Director | 1,155,862 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $49.45 per share | 57,157,375.90 |
| Apr 18, 2025 | Olivier Fabrice Duha Director | 1,162,570 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.25 per share | 56,094,002.50 |
| Mar 28, 2025 | Ann F. Vezina Director | 11,947 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 28, 2025 | Kathryn V. Marinello Director | 10,003 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 28, 2025 | Nicolas Joseph Michel Gheysens Director | 7,826 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 28, 2025 | Kathryn J. Hayley Director | 10,011 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 28, 2025 | Jennifer Deason Director | 10,003 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 28, 2025 | Te Chien Chou Director | 306 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 28, 2025 | LaVerne H. Council Director | 10,003 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 28, 2025 | Dennis J. Polk Director | 21,223 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |